Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 13
2005 23
2006 29
2007 41
2008 47
2009 68
2010 88
2011 100
2012 149
2013 193
2014 195
2015 256
2016 229
2017 320
2018 295
2019 338
2020 343
Text availability
Article attribute
Article type
Publication date

Search Results

2,439 results
Results by year
Filters applied: . Clear all
Page 1
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR.
Dimopoulos M, Siegel D, White DJ, Boccia R, Iskander KS, Yang Z, Kimball AS, Mezzi K, Ludwig H, Niesvizky R. Dimopoulos M, et al. Among authors: yang z. Blood. 2019 Jan 10;133(2):147-155. doi: 10.1182/blood-2018-06-860015. Epub 2018 Nov 26. Blood. 2019. PMID: 30478094 Free PMC article. Clinical Trial.
Hope and challenge: Precision medicine in bladder cancer.
Su H, Jiang H, Tao T, Kang X, Zhang X, Kang D, Li S, Li C, Wang H, Yang Z, Zhang J, Li C. Su H, et al. Among authors: yang z. Cancer Med. 2019 Apr;8(4):1806-1816. doi: 10.1002/cam4.1979. Epub 2019 Mar 24. Cancer Med. 2019. PMID: 30907072 Free PMC article. Review.
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups.
Orlowski RZ, Moreau P, Niesvizky R, Ludwig H, Oriol A, Chng WJ, Goldschmidt H, Yang Z, Kimball AS, Dimopoulos M. Orlowski RZ, et al. Among authors: yang z. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):522-530.e1. doi: 10.1016/j.clml.2019.04.018. Epub 2019 May 2. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31160237 Free article. Clinical Trial.
IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.
Wang JM, Qiu Y, Yang Z, Kim H, Qian Q, Sun Q, Zhang C, Yin L, Fang D, Back SH, Kaufman RJ, Yang L, Zhang K. Wang JM, et al. Among authors: yang z. Sci Signal. 2018 May 15;11(530):eaao4617. doi: 10.1126/scisignal.aao4617. Sci Signal. 2018. PMID: 29764990 Free PMC article.
[Progress in immunotherapy for hepatocellular carcinoma].
Shen Z, Li M, Bai S, Yang Q, Zhang F, Tang M, Guo J, Yang Z. Shen Z, et al. Among authors: yang z. Sheng Wu Gong Cheng Xue Bao. 2019 Dec 25;35(12):2326-2338. doi: 10.13345/j.cjb.190339. Sheng Wu Gong Cheng Xue Bao. 2019. PMID: 31880139 Free article. Review. Chinese.
Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells.
Yang Z, Li C, Fan Z, Liu H, Zhang X, Cai Z, Xu L, Luo J, Huang Y, He L, Liu C, Wu S. Yang Z, et al. Eur Urol. 2017 Jan;71(1):8-12. doi: 10.1016/j.eururo.2016.06.025. Epub 2016 Jul 4. Eur Urol. 2017. PMID: 27387124
Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
Su H, Tao T, Yang Z, Kang X, Zhang X, Kang D, Wu S, Li C. Su H, et al. Among authors: yang z. Mol Cancer. 2019 Feb 19;18(1):27. doi: 10.1186/s12943-019-0951-0. Mol Cancer. 2019. PMID: 30782157 Free PMC article.
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Yang Z, McCaw ZR, Yin G. Yang Z, et al. N Engl J Med. 2019 May 2;380(18):e32. doi: 10.1056/NEJMc1902336. N Engl J Med. 2019. PMID: 31042845 No abstract available.
HRD1-ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination.
Wei J, Chen L, Li F, Yuan Y, Wang Y, Xia W, Zhang Y, Xu Y, Yang Z, Gao B, Jin C, Melo-Cardenas J, Green RM, Pan H, Wang J, He F, Zhang K, Fang D. Wei J, et al. Among authors: yang z. EMBO J. 2018 Nov 15;37(22):e98942. doi: 10.15252/embj.201898942. Epub 2018 Nov 2. EMBO J. 2018. PMID: 30389664 Free PMC article.
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
Tan AR, Wright GS, Thummala AR, Danso MA, Popovic L, Pluard TJ, Han HS, Vojnović Ž, Vasev N, Ma L, Richards DA, Wilks ST, Milenković D, Yang Z, Antal JM, Morris SR, O'Shaughnessy J. Tan AR, et al. Among authors: yang z. Lancet Oncol. 2019 Nov;20(11):1587-1601. doi: 10.1016/S1470-2045(19)30616-3. Epub 2019 Sep 28. Lancet Oncol. 2019. PMID: 31575503 Clinical Trial.
2,439 results
Jump to page
Feedback